While therapeutic targets such as Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), and Progesteron Receptor (PR) have improved treatment strategies for certain BC subtypes, further research is needed to identify additional molecular players involved in cancer progression. The gene discussed is ERBB2; the disease is cancer.